Use of antacids Coadministration of antacids and this medicine may reduce the absorption of this medicine
doi:10.2147/IJGM.S15618Sadowska AM
10.1038/s41392-021-00679-0 Signal Transduct Target Ther
On December 20, 2024, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. AASM.org Among persons with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the AHI, body weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes. NIH study Can the makers of these new weight loss medications really claim to treat and cure Obstructive Sleep Apnea (OSA)
That kind of number instantly pushed it into the what comes after semaglutide? conversation
explained this hormetic effect of sulforaphane and revealed that SFN induces hormetic dose responses in studies through the upregulation of the Nrf2/ARE pathway
